We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+12.83%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$63.1B
AUM Growth
+$3.79B
Cap. Flow
-$1.12B
Cap. Flow %
-1.77%
Top 10 Hldgs %
32.11%
Holding
999
New
156
Increased
303
Reduced
370
Closed
127

Top Buys

Rank Stock Value
1
CVX icon
Chevron
CVX
+$509M
2
RPRX icon
Royalty Pharma
RPRX
+$216M
3
JNJ icon
Johnson & Johnson
JNJ
+$159M
4
PG icon
Procter & Gamble
PG
+$134M
5
LBRDK icon
Liberty Broadband Class C
LBRDK
+$133M

Top Sells

Rank Stock Value
1
HES
Hess
HES
+$1.35B
2
INSM icon
Insmed
INSM
+$197M
3
HUBB icon
Hubbell
HUBB
+$191M
4
ARGX icon
argenx
ARGX
+$164M
5
SLNO
Soleno Therapeutics
SLNO
+$161M

Sector Composition

Rank Sector Weight
1 Technology 30.31%
2 Healthcare 13.97%
3 Financials 11.89%
4 Consumer Discretionary 9.55%
5 Communication Services 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NXDR
801
Nextdoor Holdings
NXDR
$983M
$2.09M ﹤0.01%
+999,999
New +$1.94M
CYTK icon
802
Cytokinetics
CYTK
$11B
$2.09M ﹤0.01%
+38,000
New +$1.57M
EVTL icon
803
Vertical Aerospace
EVTL
$160M
$2.08M ﹤0.01%
+400,000
New +$2.22M
RCUS icon
804
Arcus Biosciences
RCUS
$3.56B
$2.07M ﹤0.01%
+152,000
New +$1.58M
REXR icon
805
Rexford Industrial Realty
REXR
$8.14B
$2.06M ﹤0.01%
+50,000
New +$1.96M
ADGM
806
Adagio Medical Holdings
ADGM
$16.3M
$2.05M ﹤0.01%
1,058,501
+237,240
+29% +$368K
NEXT icon
807
NextDecade
NEXT
$1.81B
$2.04M ﹤0.01%
300,000
-1,250,000
-81% -$12.1M
VSTS icon
808
Vestis
VSTS
$1.83B
$2.02M ﹤0.01%
444,844
-19,032
-4% -$97.6K
GOSS icon
809
Gossamer Bio
GOSS
$87.2M
$1.91M ﹤0.01%
+726,800
New +$1.6M
KRNY icon
810
Kearny Financial
KRNY
$604M
$1.8M ﹤0.01%
+273,925
New +$1.76M
PHR icon
811
Phreesia
PHR
$706M
$1.79M ﹤0.01%
+76,200
New +$2.07M
FLOC
812
Flowco Holdings
FLOC
$876M
$1.78M ﹤0.01%
120,000
+8,801
+8% +$149K
OVID icon
813
Ovid Therapeutics
OVID
$495M
$1.75M ﹤0.01%
1,350,000
+200,000
+17% +$173K
AAP icon
814
Advance Auto Parts
AAP
$3.49B
$1.74M ﹤0.01%
+28,380
New +$1.68M
STRO icon
815
Sutro Biopharma
STRO
$400M
$1.74M ﹤0.01%
200,000
– –
ANGO icon
816
AngioDynamics
ANGO
$625M
$1.68M ﹤0.01%
150,000
+50,000
+50% +$483K
CBU icon
817
Community Bank
CBU
$3.44B
$1.61M ﹤0.01%
27,504
+10,829
+65% +$627K
EVH icon
818
Evolent Health
EVH
$404M
$1.59M ﹤0.01%
188,524
-100,000
-35% -$970K
IRD
819
Opus Genetics
IRD
$307M
$1.58M ﹤0.01%
+954,996
New +$1.19M
MOG.A icon
820
Moog Inc Class A
MOG.A
$13B
$1.57M ﹤0.01%
7,553
– –
FDMT icon
821
4D Molecular Therapeutics
FDMT
$552M
$1.52M ﹤0.01%
+175,000
New +$1.05M
ELVN icon
822
Enliven Therapeutics
ELVN
$4.31B
$1.49M ﹤0.01%
73,000
-23,000
-24% -$464K
SAIC icon
823
Saic
SAIC
$5.25B
$1.49M ﹤0.01%
+15,000
New +$1.68M
CPRT icon
824
Copart
CPRT
$26.9B
$1.48M ﹤0.01%
32,800
-242,400
-88% -$11.4M
OC icon
825
Owens Corning
OC
$12.1B
$1.41M ﹤0.01%
+10,000
New +$1.47M
31 32
33
34 35

Similar funds

Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

Adage Capital Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Adage Capital Partners held 999 positions worth $63.1B, up 6.4% from $59.3B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Adage Capital Partners's Q3 2025 filing shows 156 new, 303 increased, 370 reduced and 127 closed positions. Its largest new stake was Chevron: 3,284,841 shares worth $510M. The largest sale was Hess, an estimated $1.35B.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q3 2025 buy was Chevron: 3,284,841 shares worth $510M.
  • Adage Capital Partners added most to Royalty Pharma in Q3 2025, an estimated $216M increase.
  • Adage Capital Partners's biggest Q3 2025 reduction was Insmed, cutting an estimated $197M.
  • Adage Capital Partners fully exited Hess in Q3 2025, selling an estimated $1.35B.
  • Adage Capital Partners's ten largest holdings make up 32% of its $63.1B portfolio in Q3 2025.
  • Adage Capital Partners opened 156 new positions and closed 127 in Q3 2025.
  • Adage Capital Partners's portfolio value rose 6.4% quarter-over-quarter to $63.1B.

Based on Adage Capital Partners's 13F filing for Q3 2025, filed 14 Nov 2025.